©2022 Stanford Medicine
Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study
Recruiting
Trial ID: NCT02685631
Purpose
This research registry studies Yttrium Y 90 resin microspheres in collecting data from
patients with liver cancer not capable of being removed by surgery (unresectable) for the
radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable
(RESIN) liver tumor registry. The information generated will help doctors better understand
treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes
for patients, as well as guide future research for using Y90 therapy, especially for those
conditions where data is currently very limited or lacking.
Official Title
Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study
Stanford Investigator(s)
David S. Wang, MD
Clinical Associate Professor, Radiology
Eligibility
Inclusion Criteria:
- Patients receiving SIR-Spheres therapy to the liver for the first time.
- Provision of written informed consent.
- Age 18 and older.
Exclusion Criteria:
1. Prior completion of Y90 therapy to the liver (SIR-Spheres, TheraSpheres, or any other
liver-targeted therapy involving the use of radiation-emitting spheres).
-Patients who have received Y90 treatment in the past and who are returning for
another Y90 treatment are ineligible, even if new areas are being targeted.
2. Need for surrogate consent. Patients unable to consent on their own behalves are not
eligible for this study.
Intervention(s):
other: Yttrium-90 Resin Microspheres
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305